Description
REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM. MODIFICATION TO INCREASE QUANTITIES FOR OPTION YEAR FOUR. MODIFICATION TO CLOSE OUT CONTRACT.
Base award description: REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-10-01+$203,363= $203,363
- Mod 72011-10-01+$203,363= $406,725
- Mod P000082012-10-10+$202,113= $608,838
- Mod P000092012-11-20+$47,808= $656,645
- Mod P000032014-11-20-$22,245= $634,400
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-10-01 | +$203,363 | $203,363 | REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM |
| Mod 7· EXERCISE AN OPTION | 2011-10-01 | +$203,363 | $406,725 | REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM |
| Mod P00008· EXERCISE AN OPTION | 2012-10-10 | +$202,113 | $608,838 | REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM |
| Mod P00009· FUNDING ONLY ACTION | 2012-11-20 | +$47,808 | $656,645 | REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM. MODIFICATION TO INCREASE QUANTITIES FOR OPTION YEAR FOUR… |
| Mod P00003· CLOSE OUT | 2014-11-20 | −$22,245 | $634,400 | REAGENTS TO BE USED WITH THE GEN-PROBE APTIMA SYSTEM. MODIFICATION TO INCREASE QUANTITIES FOR OPTION YEAR FOUR… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI QNXWLAJDL4J3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25223N0138 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $29,500 | FY2023 |
| 36C25222N0460 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,749,821 | FY2022 |
| 36C24922P0526 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $225,000 | FY2022 |
| 36C24122N0069 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $10,146 | FY2022 |
| 36C25221C0111 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $748,050 | FY2021 |
| 36C24121N0154 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $19,957 | FY2021 |
Other recipients under 6550 from 69D-NETWORK CONTRACT OFFICE 12 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA69D16J2972 | ROCHE DIAGNOSTICS CORPORATION | 69D-NETWORK CONTRACT OFFICE 12 | $48,533 | FY2016 |
| VA69D16F2333 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 69D-NETWORK CONTRACT OFFICE 12 | $21,000 | FY2016 |
| VA69D16J0812 | ROCHE DIAGNOSTICS CORPORATION | 69D-NETWORK CONTRACT OFFICE 12 | $48,516 | FY2016 |
| VA69D16C0012 | TERUMO BCT INC | 69D-NETWORK CONTRACT OFFICE 12 | $42,578 | FY2016 |
| VA69D16J0140 | ROCHE DIAGNOSTICS CORPORATION | 69D-NETWORK CONTRACT OFFICE 12 | $19,320 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69DN0018908CZ070_3600_-NONE-_-NONE- · retrieved 2026-09-26.